Predicting major outcomes in type 1 diabetes: a model development and validation study
Sabita S. Soedamah‐Muthu(The Royal Free Hospital), Trevor J. Orchard(University of Pittsburgh), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Tina Costacou(University of Pittsburgh), Valma Harjutsalo(Research Council of Finland), Marian Rewers(University of Colorado Denver), Janet K. Snell‐Bergeon(University of Colorado Anschutz Medical Campus), Janice C. Zgibor(University of South Florida), Karel G.M. Moons(University Medical Center Utrecht), David M. Maahs(Stanford University), Nish Chaturvedi(Imperial College London), Rachel G. Miller(University of Pittsburgh), John Fuller(The Royal Free Hospital), Yvonne Vergouwe(Erasmus MC)
Cited by 58
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
|BMJ|2024|2.8k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k